Insider Selling: Scott E. Way Sells 12,000 Shares of LDR Holding Corp Stock (LDRH)
LDR Holding Corp (NASDAQ:LDRH) VP Scott E. Way sold 12,000 shares of LDR Holding Corp stock on the open market in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $26.76, for a total value of $321,120.00. Following the completion of the transaction, the vice president now directly owns 3,333 shares of the company’s stock, valued at approximately $89,191. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
LDR Holding Corp (NASDAQ:LDRH) traded up 4.24% on Friday, hitting $27.07. 472,620 shares of the company’s stock traded hands. LDR Holding Corp has a 1-year low of $17.79 and a 1-year high of $40.39. The stock’s 50-day moving average is $23.67 and its 200-day moving average is $26.67. The company’s market cap is $702.9 million.
LDR Holding Corp (NASDAQ:LDRH) last issued its quarterly earnings data on Wednesday, August 6th. The company reported ($0.09) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.14) by $0.05. The company had revenue of $34.80 million for the quarter, compared to the consensus estimate of $31.14 million. The company’s revenue for the quarter was up 30.8% on a year-over-year basis. On average, analysts predict that LDR Holding Corp will post $-0.62 earnings per share for the current fiscal year.
Several analysts have recently commented on the stock. Analysts at Piper Jaffray raised their price target on shares of LDR Holding Corp from $38.00 to $40.00 in a research note on Thursday, August 7th. They now have an “overweight” rating on the stock. Analysts at RBC Capital initiated coverage on shares of LDR Holding Corp in a research note on Monday, June 23rd. They set an “outperform” rating and a $34.00 price target on the stock. Five analysts have rated the stock with a buy rating, The stock has a consensus rating of “Buy” and a consensus price target of $35.50.
LDR Holding Corporation is a global medical device company focused on designing and commercializing novel and surgical technologies for the treatment of patients suffering from spine disorders.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.